Intellia Therapeutics NTLA
NASDAQ NTLA
$12.26 +0.14 (+1.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Intellia Therapeutics (NTLA) Other Accumulated Expenses (2015 - 2026)

Updated

Intellia Therapeutics' Other Accumulated Expenses was $12.79 million in Q2 2026, down 44.2% from $22.93 million a year earlier but up 8.4% from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Other Accumulated Expenses (2015 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Intellia Therapeutics came in at $17.37 million, down 34.1% from FY2024.

  • Other Accumulated Expenses has now declined for three consecutive years, though with a five-year compound annual growth rate of 9.5% (FY2020 to FY2025).
  • In earlier years, Other Accumulated Expenses was $26.36 million in FY2024 (-3.8%), $27.41 million in FY2023 (-16.1%), $32.68 million in FY2022 (+92.5%) and $16.98 million in FY2021 (+54.2%).
  • Quarterly Other Accumulated Expenses has moved between $7.87 million (Q3 2021) and $32.68 million (Q4 2022) over five years.
  • Compared with a year earlier, Other Accumulated Expenses has declined for four straight quarters, with an average decline of 18.6% over the last eight quarters.
  • The best year-over-year quarter for Other Accumulated Expenses over five years was Q3 2022 (growth of 285.4%); the worst was Q1 2026 (a decline of 52.3%).
  • Per Business Quant data, NTLA's Other Accumulated Expenses in the three quarters before Q2 2026 was $11.79 million (Q1 2026), $17.37 million (Q4 2025) and $15.71 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Intellia Therapeutics 1.72 Bn 1.72 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.79 Mn
Mar 31, 2026 11.79 Mn
Dec 31, 2025 17.37 Mn
Sep 30, 2025 15.71 Mn
Jun 30, 2025 22.93 Mn
Mar 31, 2025 24.73 Mn
Dec 31, 2024 26.36 Mn
Sep 30, 2024 24.33 Mn
Jun 30, 2024 21.96 Mn
Mar 31, 2024 21.20 Mn
Dec 31, 2023 27.41 Mn
Sep 30, 2023 24.24 Mn
Jun 30, 2023 25.44 Mn
Mar 31, 2023 26.23 Mn
Dec 31, 2022 32.68 Mn
Sep 30, 2022 30.35 Mn
Jun 30, 2022 25.28 Mn
Mar 31, 2022 21.38 Mn
Dec 31, 2021 16.98 Mn
Sep 30, 2021 7.87 Mn
API Access

Intellia Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NTLA&period=max&api_key=YOUR_API_KEY